You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Claims for Patent: 10,232,004

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,232,004

Title:	Pharmaceutical composition based on Centella asiatica (Hydrocotyle asiatica L.) for the treatment of lower limb ulcers
Abstract:	A pharmaceutical composition based on centella asiatica (Hydrocotyle asiatica L.) for the treatment of lower limb ulcers, including as active ingredients, centella asiatica and sodium acexamate in amounts producing a reciprocal synergistic effect when mixed with at least one adjuvant selected from a healing agent, an antibiotic agent and/or combinations thereof is described.
Inventor(s):	Montanez-Soto; Flor Lucia (Veracruz, MX)
Assignee:
Application Number:	14/784,085
Patent Claims:	1. A pharmaceutical composition based on centella asiatica (Hydrocotyle asiatica L.) for the treatment of lower limb ulcers, comprising about 10% to 18% by weight of centella asiatica, about 67% to 75% by weight of sodium acexamate, and about 10% to 18% by weight of an antibiotic agent. 2. A pharmaceutical composition based on centella asiatica (Hydrocotyle asiatica L.) for the treatment of lower limb ulcers according to claim 1, further comprising about 60 U of collagenase. 3. A pharmaceutical composition based on centella asiatica (Hydrocotyle asiatica L.) for the treatment of lower limb ulcers according to claim 2, wherein the collagenase is clostridiopeptidase A. 4. A pharmaceutical composition based on centella asiatica (Hydrocotyle asiatica L.) for the treatment of lower limb ulcers according to claim 1, wherein the antibiotic agent is selected from chloramphenicol, sulfathiazole powder, and ciprofloxacin. 5. A pharmaceutical composition based on centella asiatica (Hydrocotyle asiaticaL.) for the treatment of lower limb ulcers according to claim 2, wherein the composition comprises a bout 14% by weight of centella asiatica; about 71% by weight of sodium acexamate; about 14% by weight of chloramphenicol; and about 60 U of collagenase. 6. A pharmaceutical composition based on centella asiatica (Hydrocotyle asiaticaL.) for the treatment of lower limb ulcers according to claim 1 wherein the composition comprises about 14% by weight of centella asiatica; about 71% by weight of sodium acexamate; and about 14% by weight of sulfathiazole powder. 7. A pharmaceutical composition based on centella asiatica (Hydrocotyle asiatica L.) for the treatment of lower limb ulcers according to claim 1 wherein the composition comprises about 14% by weight of centella asiatica; about 71% by weight of sodium acexamate; and about 14% by weight of ciprofloxacin. 8. A method for treatment of lower limb ulcers comprising administering to a subject in need a medicament comprising a pharmaceutical composition based on centella asiatica (Hydrocotyle asiatica L.) as claimed in claim 1.

Details for Patent 10,232,004

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965	⤷ Try a Trial	2033-04-11
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.